PQS: NSAID quality criterion

PQS: NSAID quality criterion

December 12, 2019

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS) of which community pharmacy contractors should be aware.

Implementing the findings and recommendations from the 2018/19 Quality Payments Scheme NSAID audit report

Contractors are required to have implemented the findings and recommendations from the 2018/19 Quality Payments Scheme NSAID safety audit report as part of the requirements to meet the NSAID quality criterion. They will be asked if they have implemented the findings and recommendations when they complete their PQS declaration and they may be asked to demonstrate how they have done this during post-payment verification.

Update to the SPS NSAID audit

Contractors who are in the process of completing the Specialist Pharmacy Service (SPS) NSAID audit or have not yet started it, are advised that minor updates have been made to the list of NSAIDs included in the audit (tranexamic acid was inadvertently listed in the earlier version of the audit). Contractors are therefore advised to use the updated audit, which is now available on the SPS website. A standalone version of the updated audit data collection form is also available on the PSNC website.

Contractors who have already completed the NSAID audit are not required to take any action.

Sharing anonymised patient data with NHS England and NHS Improvement

To meet the NSAID quality criterion, contractors are required to share their anonymised patient data from the NSAID audit with NHS England and NHS Improvement; this must be done before the contractor makes their PQS declaration. The anonymised patient data needs to be submitted on the NHS Business Services Authority’s (NHSBSA) Manage Your Service (MYS) portal or via PharmOutcomes (please note, contractors should only use one of these systems for this audit).

If contractors have already completed the audit, the anonymised patient data can be added to MYS or PharmOutcomes now; you don’t need to wait until the PQS declaration window opens, to submit the data.

Further information on meeting the NSAID quality criterion can be found at: psnc.org.uk/pqsnsaid



Posted in: , ,


More Latest News >

Wuhan Novel Coronavirus

The Medicines & Healthcare products Regulatory Agency (MHRA) has via its Central Alerting System (CAS) published an alert regarding the...